News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
716,361 Results
Type
Article (42428)
Company Profile (437)
Press Release (673496)
Multimedia
Podcasts (80)
Webinars (13)
Section
Business (208890)
Career Advice (2022)
Deals (36018)
Drug Delivery (104)
Drug Development (83644)
Employer Resources (173)
FDA (16452)
Job Trends (15113)
News (353054)
Policy (33115)
Tag
Academia (2647)
Accelerated approval (6)
Adcomms (24)
Allergies (88)
Alliances (51008)
ALS (101)
Alzheimer's disease (1436)
Antibody-drug conjugate (ADC) (147)
Approvals (16434)
Artificial intelligence (281)
Autoimmune disease (26)
Automation (17)
Bankruptcy (372)
Best Places to Work (11846)
BIOSECURE Act (19)
Biosimilars (107)
Biotechnology (331)
Bladder cancer (84)
Brain cancer (27)
Breast cancer (301)
Cancer (2389)
Cardiovascular disease (192)
Career advice (1690)
Career pathing (30)
CAR-T (163)
Cell therapy (460)
Cervical cancer (20)
Clinical research (67937)
Collaboration (903)
Company closure (2)
Compensation (578)
Complete response letters (24)
COVID-19 (2651)
CRISPR (47)
C-suite (263)
Cystic fibrosis (107)
Data (2376)
Decentralized trials (2)
Denatured (29)
Depression (52)
Diabetes (280)
Diagnostics (6442)
Digital health (20)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (127)
Drug pricing (112)
Drug shortages (26)
Duchenne muscular dystrophy (103)
Earnings (88378)
Editorial (43)
Employer branding (21)
Employer resources (147)
Events (116310)
Executive appointments (763)
FDA (17855)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (809)
Gene editing (119)
Generative AI (21)
Gene therapy (343)
GLP-1 (759)
Government (4520)
Grass and pollen (4)
Guidances (162)
Healthcare (19161)
Huntington's disease (25)
IgA nephropathy (31)
Immunology and inflammation (140)
Indications (30)
Infectious disease (2799)
Inflammatory bowel disease (150)
Inflation Reduction Act (11)
Influenza (53)
Intellectual property (100)
Interviews (312)
IPO (16812)
IRA (43)
Job creations (3705)
Job search strategy (1434)
Kidney cancer (10)
Labor market (43)
Layoffs (507)
Leadership (18)
Legal (7988)
Liver cancer (77)
Lung cancer (333)
Lymphoma (159)
Machine learning (9)
Management (58)
Manufacturing (338)
MASH (80)
Medical device (13537)
Medtech (13542)
Mergers & acquisitions (19775)
Metabolic disorders (743)
Multiple sclerosis (85)
NASH (19)
Neurodegenerative disease (108)
Neuropsychiatric disorders (33)
Neuroscience (2033)
NextGen: Class of 2025 (6759)
Non-profit (4552)
Now hiring (40)
Obesity (394)
Opinion (224)
Ovarian cancer (83)
Pain (96)
Pancreatic cancer (89)
Parkinson's disease (161)
Partnered (22)
Patents (248)
Patient recruitment (117)
Peanut (47)
People (58754)
Pharmaceutical (86)
Pharmacy benefit managers (20)
Phase I (21365)
Phase II (29982)
Phase III (22148)
Pipeline (1410)
Policy (156)
Postmarket research (2601)
Preclinical (9169)
Press Release (67)
Prostate cancer (112)
Psychedelics (37)
Radiopharmaceuticals (264)
Rare diseases (411)
Real estate (6015)
Recruiting (66)
Regulatory (22818)
Reports (47)
Research institute (2420)
Resumes & cover letters (351)
Rett syndrome (6)
RNA editing (5)
RSV (42)
Schizophrenia (80)
Series A (141)
Series B (96)
Service/supplier (11)
Sickle cell disease (58)
Special edition (19)
Spinal muscular atrophy (152)
Sponsored (30)
Startups (3767)
State (2)
Stomach cancer (14)
Supply chain (69)
Tariffs (50)
The Weekly (49)
Vaccines (719)
Venture capitalists (44)
Weight loss (258)
Women's health (38)
Worklife (17)
Date
Today (177)
Last 7 days (967)
Last 30 days (3273)
Last 365 days (33509)
2025 (12262)
2024 (36305)
2023 (41017)
2022 (52287)
2021 (56773)
2020 (54929)
2019 (47431)
2018 (35709)
2017 (33034)
2016 (32364)
2015 (38423)
2014 (32199)
2013 (27128)
2012 (29240)
2011 (29876)
2010 (28018)
Location
Africa (739)
Alabama (59)
Alaska (7)
Arizona (241)
Arkansas (14)
Asia (39337)
Australia (6560)
California (6569)
Canada (2079)
China (555)
Colorado (281)
Connecticut (295)
Delaware (161)
Europe (86085)
Florida (961)
Georgia (216)
Idaho (57)
Illinois (567)
India (25)
Indiana (327)
Iowa (12)
Japan (174)
Kansas (109)
Kentucky (25)
Louisiana (12)
Maine (62)
Maryland (943)
Massachusetts (4970)
Michigan (228)
Minnesota (411)
Mississippi (2)
Missouri (83)
Montana (29)
Nebraska (25)
Nevada (68)
New Hampshire (67)
New Jersey (1837)
New Mexico (30)
New York (1834)
North Carolina (1059)
North Dakota (8)
Northern California (2875)
Ohio (213)
Oklahoma (14)
Oregon (38)
Pennsylvania (1447)
Puerto Rico (13)
Rhode Island (34)
South America (1113)
South Carolina (26)
South Dakota (1)
Southern California (2453)
Tennessee (106)
Texas (971)
United States (24691)
Utah (191)
Virginia (156)
Washington D.C. (66)
Washington State (590)
West Virginia (3)
Wisconsin (57)
716,361 Results for "tg therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
TG Therapeutics to Host Conference Call on First Quarter 2025 Financial Results and Business Update
April 30, 2025
·
1 min read
Press Releases
TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance
May 5, 2025
·
20 min read
Press Releases
TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals
April 7, 2025
·
14 min read
Press Releases
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting
April 8, 2025
·
14 min read
Press Releases
MaxCyte Signs Strategic Platform License with TG Therapeutics to Advance its Autoimmune Cell Therapeutics Programs
February 12, 2025
·
6 min read
Press Releases
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
March 4, 2025
·
21 min read
Press Releases
TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2024 Financial Results and Business Update
February 26, 2025
·
1 min read
Press Releases
TG Therapeutics to Participate in the Evercore HealthCONx Conference
December 2, 2024
·
1 min read
Press Releases
TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
January 9, 2025
·
1 min read
Press Releases
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting
March 10, 2025
·
15 min read
1 of 71,637
Next
